Detalles de la búsqueda
1.
Cisplatin Monotherapy as a Treatment Option for Patients with HER-2 Negative Breast Cancer Experiencing Hepatic Visceral Crisis or Impending Visceral Crisis.
Oncol Ther;
2024 Jun 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38833126
2.
Non-metastatic primary neuroendocrine neoplasms of the breast: a reference cancer center's experience of a heterogenous entity.
Front Endocrinol (Lausanne);
15: 1217495, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38800480
3.
Clinical analysis of metaplastic breast carcinoma with distant metastases: A multicentre experience.
Oncol Lett;
27(5): 198, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38516685
4.
Shifting Treatment Paradigms: Improvements in HR-Positive, HER-2- Negative Breast Cancer Care in Poland from a Clinical Perspective.
Biomedicines;
11(2)2023 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36831045
5.
Cancer care for Ukrainian refugees during the first 6 weeks of 2022 Russian invasion - An experience of a cancer reference centre in Poland.
Eur J Cancer;
178: 234-242, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36371305
6.
Discrepancy between Tumor Size Assessed by Full-Field Digital Mammography or Ultrasonography (cT) and Pathology (pT) in a Multicenter Series of Breast Metaplastic Carcinoma Patients.
Cancers (Basel);
16(1)2023 Dec 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38201615
7.
Early Effects of Nivolumab and Ipilimumab Combined Immunotherapy in the Treatment of Metastatic Melanoma in Poland: A Multicenter Experience.
Biomedicines;
10(10)2022 Oct 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36289790
8.
Biomarkers of Trastuzumab-Induced Cardiac Toxicity in HER2- Positive Breast Cancer Patient Population.
Cancers (Basel);
14(14)2022 Jul 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35884413
9.
Effective Treatment of a Melanoma Patient with Hemophagocytic Lymphohistiocytosis after Nivolumab and Ipilimumab Combined Immunotherapy.
Prague Med Rep;
123(1): 35-42, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35248163
10.
Adjuvant combined therapy with trastuzumab in patients with HER2 positive breast cancer and cardiac alterations: implications for optimal cardiooncology care.
Pol Arch Intern Med;
132(4)2022 04 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35089680
11.
Low frequency of HPV positivity in breast tumors among patients from south-central Poland.
Infect Agent Cancer;
16(1): 67, 2021 Nov 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-34838092
12.
Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma.
J Clin Oncol;
39(9): 1029-1039, 2021 03 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-33529058
13.
Primary cardiac atrial sarcomas. Report of two histologically different cases and review of the literature.
Pol J Pathol;
72(4): 358-369, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-35308009
14.
BRAF and MEK inhibitors rechallenge as effective treatment for patients with metastatic melanoma.
Melanoma Res;
30(5): 465-471, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32221131
15.
Immune checkpoint inhibitors therapy in older patients (≥ 70 years) with metastatic melanoma: a multicentre study.
Postepy Dermatol Alergol;
36(5): 566-571, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31839773
16.
Principles of prophylactic and therapeutic management of skin toxicity during treatment with checkpoint inhibitors.
Postepy Dermatol Alergol;
36(4): 382-391, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31616210
17.
High baseline neutrophil-to-lymphocyte ratio predicts worse outcome in patients with metastatic BRAF-positive melanoma treated with BRAF and MEK inhibitors.
Melanoma Res;
28(5): 435-441, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29782381
18.
Prognostic role of lymphatic vessel density and lymphovascular invasion in chemotherapy-naive and chemotherapy-treated patients with invasive breast cancer.
Am J Transl Res;
9(3): 1435-1447, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28386369
19.
The search for optimal cutoff points for apoptosis and proliferation rate in prognostification of early stage breast cancer patients treated with anthracyclines in adjuvant settings.
Tumour Biol;
37(6): 7645-55, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26687650
20.
BCL-2, topoisomerase IIα, microvessel density and prognosis of early advanced breast cancer patients after adjuvant anthracycline-based chemotherapy.
J Cancer Res Clin Oncol;
140(12): 2009-19, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25005788